COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,100 Articles (22,658 medRxiv, 8,442 bioRxiv)

Most recent first Previous |  Page 889: Articles 8881-8890  | Next

Short-term improvement of mental health after a COVID-19 vaccination
Chourpiliadis, C., Lovik, A., Kahler, A. K., Valdimarsdottir, U., Frans, E. M., Nyberg, F., Sullivan, P. F., Fang, F.
10.1101/2022.02.22.22271327 — Posted: 2022-02-27
Impact of Omicron variant on the response to SARS-CoV-2 mRNA vaccination in multiple myeloma and monoclonal gammopathies
Storti, P., Marchica, V., Vescovini, R., Franceschi, V., Russo, L., Raimondi, V., Toscani, D., Burroughs Garcia, J., Costa, F., Dalla Palma, B., Soressi, N., Giaimo, M., Iannozzi, N. T., Notarfranchi, L., Sammarelli, G., Donofrio, G., Giuliani, N.
10.1101/2022.02.25.22271501 — Posted: 2022-02-26
Follow-up investigation and detailed mutational characterization of the SARS-CoV-2 Omicron variant lineages (BA.1, BA.2, BA.3 and BA.1.1)
Abbas, Q., Kusakin, A. V., Sharrouf, K., Jyakhwo, S., Komissarov, A. S.
10.1101/2022.02.25.481941 — Posted: 2022-02-26
Proteomic analysis of human milk reveals nutritional and immune benefits in the colostrum from mothers with COVID-19
Guo, J., Tan, M., Zhu, J., Tian, Y., Liu, H., Luo, F., Wang, J., Huang, Y., Zhang, Y., Yang, Y., Wang, G.
10.1101/2022.02.25.481966 — Posted: 2022-02-26
Protection of Hamsters Challenged with SARS-CoV-2 after Two Doses of MVC-COV1901 Vaccine Followed by a Single Intranasal Booster with Nanoemulsion Adjuvanted S-2P Vaccine
Lin, Y.-J., Lin, M.-Y., Chuang, Y.-S., Liu, L. T. C., Kuo, T.-Y., Chen, C., Ganesan, S., Fattom, A., Bitko, V., Lien, C.-E.
10.1101/2022.02.24.481901 — Posted: 2022-02-26
Discovery of a novel coronavirus in Swedish bank voles (Myodes glareolus)
Wasberg, A., Raghwani, J., Li, J., Pettersson, J. H.- O., Lindahl, J., Lundkvist, A., Ling, J.
10.1101/2022.02.24.481848 — Posted: 2022-02-26
Adenosine A2A Receptor (A2AR) agonists improve survival in K28-hACE2 mice following SARS CoV-2 infection
Mann, B. J., Chhabra, P., Ma, M., Brovero, S. G., Jones, M. K., Linden, J. M., Brayman, K. L.
10.1101/2022.02.25.481997 — Posted: 2022-02-26
A structural dynamic explanation for observed escape of SARS-CoV-2 BA.2 variant mutation S371L/F
Miller, N. L., Clark, T., Raman, R., Sasisekharan, R.
10.1101/2022.02.25.481957 — Posted: 2022-02-26
Transcriptomic landscapes of SARS-CoV-2-infected and bystander lung cells reveal a selective upregulation of NF-κB-dependent coding and non-coding proviral transcripts
Szachnowski, U., Bhargava, A., Chazal, M., Foretek, D., Aicher, S.-M., Pipoli da Fonseca, J., Jeannin, P., Beauclair, G., Monot, M., Morillon, A., Jouvenet, N.
10.1101/2022.02.25.481978 — Posted: 2022-02-26
Shifting mutational constraints in the SARS-CoV-2 receptor-binding domain during viral evolution
Starr, T. N., Greaney, A. J., Hannon, W. W., Loes, A. N., Hauser, K., Dillen, J. R., Ferri, E., Ghez Farrell, A., Dadonaite, B., McCallum, M., Matreyek, K. A., Corti, D., Veesler, D., Snell, G., Bloom, J. D.
10.1101/2022.02.24.481899 — Posted: 2022-02-26

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).